logo

For the Inventor, By the Inventor

South Yarra, Australia

Vegenics Pty Limited


USPTO Granted Patents = 22

% Expired Patents = 59.1


Forward Citations = 45

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Kari Alitalo (16 out of 72 patents)

silverMedal Marc Gregory Achen (5 out of 24 patents)

bronzeMedal Markku Michael Jeltsch (4 out of 10 patents)

4.  Michael Gerometta (3 out of 3 patents)

5.  Andrew Frederick Wilks (3 out of 34 patents)

6.  Steven Alan Stacker (3 out of 22 patents)

7.  Timothy Edward Adams (3 out of 8 patents)

8.  Megan E Baldwin (2 out of 4 patents)

9.  Kameran Lashkari (2 out of 9 patents)

10.  Jie Ma (2 out of 2 patents)

11.  Karl B Lemström (2 out of 2 patents)

12.  Antti I Nykänen (2 out of 2 patents)

13.  Taija Makinen (2 out of 4 patents)

14.  Vladimir Joukov (2 out of 16 patents)

15.  Ulf Eriksson (1 out of 43 patents)


22 patents:

1. 11866739 - Ligand binding molecules and uses thereof (2024-01-09),
2. 11209444 - Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization (2021-12-28),
3. 10494617 - Ligand binding molecules and uses thereof (2019-12-03),
4. 10274503 - Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis (2019-04-30),
5. 9896499 - Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis (2018-02-20),
6. 9745558 - VEGFR-3 ligand binding molecules and uses thereof (2017-08-29),
7. 9260526 - Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy (2016-02-16),
8. 9073997 - Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis (2015-07-07),
9. 8940695 - Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy (2015-01-27),
10. 8759286 - Pharmaceutical compositions comprising a VEGF-D polypeptide (2014-06-24),
11. 8637262 - Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof (2014-01-28),
12. 8461109 - Method of enhancing the acceptance and/or healing of a skin graft (2013-06-11),
13. 8455453 - Use of VEGF-D gene to prevent restenosis (2013-06-04),
14. 8444957 - Methods of screening for neoplastic disease states (2013-05-21),
15. 8383788 - C-Fos induced growth factor (FIGF) and DNA encoding same (2013-02-26),
Company Overview
Vegenics Pty Limited, based in South Yarra, Australia, specializes in the development and manufacturing of innovative plant-based products. The company focuses on creating sustainable solutions that cater to the growing demand for alternative food sources. With a commitment to research and technology, Vegenics is at the forefront of advancements in the plant-based sector, aiming to enhance nutritional profiles and promote environmental sustainability. Their expertise spans various domains, including food science and agricultural technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Vegenics Pty Limited USPTO Patent Assignee Logo
22 Patents

#2 in South Yarra

#148 in Australia

#28,807 in the World

South Yarra, AU
South Yarra, Australia

Vegenics Pty Limited

Forward Citations = 45

31 inventors:

goldMedal Kari Alitalo (16 out of 72 patents)

silverMedal Marc Gregory Achen (5 out of 24 patents)

bronzeMedal Markku Michael Jeltsch (4 out of 10 patents)

4.  Michael Gerometta (3 out of 3 patents)

5.  Andrew Frederick Wilks (3 out of 34 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vegenics Pty Limited. Retrieved from https://idiyas.com/company/vegenics-pty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…